NCT04584177

Brief Summary

A pilot cross-over RCT including participants with sub-acute stroke is conducted in an inpatient rehabilitation setting. The experimental group (EG) receives an arm-hand boost program on top of their usual care program. The control group (CG) receives a dose-matched program of strengthening exercises for the lower limbs and general reconditioning. After 4 weeks, a cross-over is performed. Before, after 4 weeks and after 8 weeks of additional therapy, different clinical outcome measures for the upper limb are administered.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 9, 2019

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 4, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 12, 2020

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2020

Completed
Last Updated

February 11, 2021

Status Verified

August 1, 2020

Enrollment Period

1.5 years

First QC Date

September 4, 2020

Last Update Submit

February 10, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change from Fugl-Meyer Assessment-Upper Extremity at 4 weeks

    UL assessment - Function

    Between baseline and first 4 weeks of study

  • Change from Fugl-Meyer Assessment-Upper Extremity at 8 weeks

    UL assessment - Function

    Between baseline and end of study (=8 weeks)

  • Change from Action Research Arm Test at 4 weeks

    UL Assessment - Activities

    Between baseline and first 4 weeks of study

  • Change from Action Research Arm Test at 8 weeks

    UL Assessment - Activities

    Between baseline and end of study (=8 weeks)

Secondary Outcomes (8)

  • Change from Jebsen Taylor hand function test at 4 weeks

    Between baseline and first 4 weeks of study

  • Change from Jebsen Taylor hand function test at 8 weeks

    Between baseline and end of study (=8 weeks)

  • Change from Rivermead Motor Assessment Arm function at 4 weeks

    Between baseline and first 4 weeks of study

  • Change from Rivermead Motor Assessment Arm function at 8 weeks

    Between baseline and end of study (=8 weeks)

  • Change from Stroke upper limb capacity scale (SULCS) at 4 weeks

    Between baseline and first 4 weeks of study

  • +3 more secondary outcomes

Study Arms (2)

Arm-hand BOOST + Control

EXPERIMENTAL

First 4 weeks arm-hand boost program, afterwards, 4 weeks of control program

Behavioral: Arm-hand BOOST programBehavioral: Control program

Control + Arm-hand BOOST

EXPERIMENTAL

First 4 weeks control program, afterwards 4 weeks arm-hand boost program

Behavioral: Arm-hand BOOST programBehavioral: Control program

Interventions

The arm-hand boost program is provided 1 hour/day, 5x/week for 4 weeks, on top of their usual care program. The focus of the boost program is on scapula-setting, core-stability when reaching, movements with 30-60° flexion/abduction in shoulder, fine manipulation and integration in complex ADL tasks. Additionally, patients exercise 1 hour per week using the Armeo Power (Hocoma). Therefore, the additional arm-hand boost program consists of 24 one-hour sessions, provided over four weeks.

Arm-hand BOOST + ControlControl + Arm-hand BOOST
Control programBEHAVIORAL

A dose-matched program of strengthening exercises for the lower limbs and general reconditioning

Arm-hand BOOST + ControlControl + Arm-hand BOOST

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first stroke, as defined by WHO,
  • minimal stay of 4 weeks in inpatient setting at study start
  • minimally 18 years old
  • being able to sit independently (trunk control test, item 3 = 25),
  • motor impairment in the upper limb (Fugl-Meyer assessment, stage 2 (synergies): 8-17p, or stage 2: \<8p combined witht stage 5 (hand): \>6p
  • sufficient cooperation to perform intervention and evaluations

You may not qualify if:

  • musculoskeletal and/or other neurological impairments with permanent damage that may hinder the study
  • subdural hematoma, tumor, encephalitis, trauma, or other that lead to similar symptoms as stroke
  • severe communication, cognitive or language impairments that hinder the investigations
  • no written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jessa Hospital, Campus Sint-Ursula

Herk-de-Stad, 3540, Belgium

Location

Related Publications (1)

  • Meyer S, Verheyden G, Kempeneers K, Michielsen M. Arm-Hand Boost Therapy During Inpatient Stroke Rehabilitation: A Pilot Randomized Controlled Trial. Front Neurol. 2021 Feb 26;12:652042. doi: 10.3389/fneur.2021.652042. eCollection 2021.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Sarah Meyer, PhD

    Jessa Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2020

First Posted

October 12, 2020

Study Start

May 9, 2019

Primary Completion

November 3, 2020

Study Completion

November 3, 2020

Last Updated

February 11, 2021

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations